Gastrointestinal stromal tumors: Should they be treated with the same systemic chemotherapy as other soft tissue sarcomas?: A co-operative study by the Italian sarcoma group [2]

Oncology

Volumn 64, Issue 2, 2003, Pages 186-188

  De Pas, Tommaso ^a   Casali, Paolo G ^b   Toma, Salvatore ^c   Romanini, Antonella ^d   Massidda, Bruno ^e   Comandone, Alessandro ^f   Labianca, Roberto ^g   Massacesi, Christian ^h   Tucci, Aniello ⁱ   Antimi, Mauro ^j   Biasco, Guido ^k   Aglietta, Massimo ^l   Apice, Gaetano ^m   De Braud, Filippo ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d SANTA CHIARA HOSPITAL   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f H Gradenigo ^*  (Italy)

^g OSPEDALI RIUNITI   (Italy)

^h UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

ⁱ Division of Medical Oncology   (Italy)

^j Division of Medical Oncology   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l MAURIZIANO HOSPITAL   (Italy)

^m NATIONAL CANCER INSTITUTE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; IMATINIB;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; KAPLAN MEIER METHOD; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GASTROINTESTINAL NEOPLASMS; HUMANS; IFOSFAMIDE; ITALY; RETROSPECTIVE STUDIES; SARCOMA; STROMAL CELLS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037261953     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067773     Document Type: Letter

References (7)

1. Rosaj J: Gastrointestinal tract; in Ackerman (ed): Surgical Pathology, ed 8. St Louis, Mosby, 1996, pp 644-647.
2. Zalupski M, Metch B, Balcerzak S, et al: Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft tissue sarcomas: A Southwest Oncology Group Study. J Nat Cancer Inst 1991;83:926-932.
3. Plager C, Papadopoulos NE, Salem P, et al: Adriamycin based chemotherapy for leiomyosarcoma of the stomach and small bowel. Proc Am Soc Clin Oncol 1991:abstr 1251.
4. Patel SR, Legha SS, Salem PA: Evaluation of ifosfamide in metastatic leiomyosarcoma of gastrointestinal origin. Proc Am Soc Clin Oncol 1991:abstr 1252.
5. Celik C, Lopez C, Douglass HO Jr: Advanced leiomyosarcoma of the stomach. J Surg Oncol 1984;26:83-85.
6. Choi TK, Ng A, Wong J: Doxorubicin, dacarbazine, vincristine, and cyclophosphamide in the treatment of advanced gastrointestinal leiomyosarcoma. Cancer Treat Rep 1985;69:443-444.
7. Conlon KC, Casper ES, Brennan MF: Primary gastrointestinal sarcomas: Analysis of prognostic variables. Ann Surg Oncol 1995;2:26-31.